WELCOME TO MEDSIR!
Here we are dedicated to the design and management of clinical trials involving some of the most important current drugs in Oncology such as osimertinib, pembrolizumab, pertuzumab, T-DM1, olaparib, niraparib, eribulin, palbociclib, fulvestrant, radium-223 and many more and we’d be thrilled to help you transform your idea into a high-level strategic clinical trial by applying our simple method:
First off, you confidentially send us your idea… a few lines, or a short synopsis is all we need.
Then, your idea will be reviewed by our network of cancer experts while our statistician develops a realistic scenario for the study to be carried out.
Lastly, we confidentially present the proposal to a potential funder, negotiating a win-win situation that satisfies all parties.
If the project is approved, you will join our team and play a lead role in all study aspects all the way through to the publication of study results. Meanwhile, our clinical operations team professionally manages the trial, respecting ISO 9001-certified quality, while placing a major focus on accrual timelines: The faster we move, the quicker we can produce results and improve patient lives.